Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model

• Published in: Experimental eye research Vol. 203; p. 108391
• Main Authors: Kim, Soo-Young, Kambhampati, Siva P., Bhutto, Imran A., McLeod, D. Scott, Lutty, Gerard A., Kannan, Rangaramanujam M.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2021
• Subjects: Age- related macular degeneration; Animals; Biomarkers - metabolism; Blotting, Western; Choroidal neovascularization; Choroidal Neovascularization - etiology; Choroidal Neovascularization - metabolism; Choroidal Neovascularization - pathology; Disease Models, Animal; Geographic Atrophy - chemically induced; Geographic Atrophy - pathology; In Situ Nick-End Labeling; Inflammation; Inflammation - etiology; Inflammation - metabolism; Inflammation - pathology; Lipid Peroxides - toxicity; Microglia/macrophages; Microscopy, Confocal; Oxidative stress; Oxidative Stress - drug effects; Photoreceptor Cells, Vertebrate - drug effects; Photoreceptor Cells, Vertebrate - pathology; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Retinal Neovascularization - etiology; Retinal Neovascularization - metabolism; Retinal Neovascularization - pathology; Retinal Pigment Epithelium - drug effects; Retinal Pigment Epithelium - pathology; Wet Macular Degeneration - chemically induced; Wet Macular Degeneration - pathology; Microglia/macrophages; Oxidative stress; Inflammation; Age- related macular degeneration; Choroidal neovascularization
• ISSN: 0014-4835; 1096-0007
• DOI: 10.1016/j.exer.2020.108391

Oxidative stress, inflammation and neovascularization are the key pathological events that are implicated in human age-related macular degeneration (AMD). There are a limited number of animal models available for evaluating and developing new therapies. Most models represent late exudative or neovascular AMD (nAMD) but there is a relative paucity of models that mimic early events in AMD. The purpose of this study is to characterize the evolution of oxidative stress, inflammation, retinal degeneration and neovascularization in a rat model of AMD, created by subretinal injection of human lipid hydroperoxide (HpODE) that found in the sub-macular region in aged and AMD patients. Subretinal HpODE induced retinal pigment epithelium (RPE) and retinal degeneration resulting in loss of RPE cells, photoreceptors and retinal thinning. RPE degeneration and atrophy were detected by day 5, followed by neural tissue degeneration at day 12 with robust TUNEL positive cells. Western blot analysis confirmed an increase in pro-apoptotic Bak protein at day 12 in retinal tissues. Oxidative damage biomarkers (4-hydroxynonenal, malondialdehyde, 8-hydroxy-2′-deoxyguanosine, and nitrotyrosine) increased in retinal tissue from days 5–12. Müller glial activation was observed in the HpODE injected area at day 5 followed by its remodeling and migration in the outer retina by day 20. RT-qPCR analysis further indicated upregulation of pro-inflammatory genes (TNF-α, IL-1β and IL-6) both in retinal and RPE/choroidal tissue as early as day 2 and persisted until day 12. Upregulation of oxidative stress markers such as NADPH oxidase (NOX and DOUX family) was detected early in retinal tissue by day 2 followed by its upregulation in choroidal tissue at day 5. Neovascularization was demonstrated from day 12 to day 20 post HpODE injection in choroidal tissue. The results from this study indicate that subretinal HpODE induces advanced AMD phenotypes comprising many aspects of both dry/early and late) and neovascular/late AMD as observed in humans. Within 3 weeks via oxidative damage, upregulation of reactive oxygen species and pro-inflammatory genes, pro-apoptotic Bak and pro-angiogenic VEGF upregulation occurs leading to CNV formation. This experimental model of subretinal HpODE is an appropriate model for the study of AMD and provides an important platform for translational and basic research in developing new therapies particularly for early/dry AMD where currently no viable therapies are available. [Display omitted] •Oxidative stress, inflammation and neovascularization are the key pathological events implicated in human AMD.•Subretinal lipid AMD model mirrors many aspects of early/dry AMD and late/neovascular AMD.•In retina oxidative stress occurs first and is persistent whereas in RPE/choroid oxidative stress evolves in a delayed manner and is transient.•Neovascularization happens late in choroid and extends into retina as observed in human AMD.•This model provides an important platform for translational and basic research in developing new therapies for AMD.